Sign In to Follow Application
View All Documents & Correspondence

Combination Therapies And Methods For Myelin Growth And Treatment Of Age Related Hearing Loss

Abstract: Embodiments of the present disclosure generally relate to combination therapies and methods for myelin growth and/or remyelination. Embodiments described herein also relate to such combination therapies and methods used for the treatment of various diseases or medical conditions, such as age-related hearing loss, in a patient. In an embodiment, a combination therapy for stimulating remyelination of a neuron in a patient having hearing loss is provided. The combination therapy includes a pharmaceutical or pharmaceutical composition, the pharmaceutical or pharmaceutical composition comprising an antihistamine, a remyelination therapy, a therapy prescribed for treatment of multiple sclerosis, or combinations thereof. The combination therapy further includes an audio file configured to facilitate remyelination of a neuron upon administration of the pharmaceutical or pharmaceutical composition.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
13 October 2026
Publication Number
42/2026
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
Parent Application

Applicants

1. THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
1800 Grant Street, 8th floor Denver, Colorado 80203

Inventors

1. KLUG, Achim
1890 N Revere Ct Suite 6202, Mail Stop F411 Denver, Colorado 80045
2. TOLLIN, Daniel
1890 N Revere Ct Suite 6202, Mail Stop F411 Denver, Colorado 80045
3. HUGHES, Ethan
1890 N Revere Ct Suite 6202, Mail Stop F411 Denver, Colorado 80045
4. POLEG, Shani
1890 N Revere Ct Suite 6202, Mail Stop F411 Denver, Colorado 80045

Specification

Documents